TNFSF18 and cancer: Tumor cells from cancers such as breast, ovarian, and prostate have been shown to induce platelet activation, leading to platelet aggregation and the expression of key surface molecules, including glucocorticoid-induced TNF-related ligand (GITRL) and P-selectin [121].